MDRX — Veradigm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual cashflow statement for Veradigm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-154	408	-183	-133	134
Depreciation
Deferred Taxes
Non-Cash Items	197	-476	78.1	-10.8	-360
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	57.7	-60.1	-18.4	-152	-23.5
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	248	67.9	46.3	-107	-75.4
Capital Expenditures	-157	-145	-130	-105	-78.6
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	-256	393	-30.6	1,720	66.4
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-413	248	-161	1,615	-12.2
Financing Cash Flow Items	23.5	128	-93	-10.4	-16.4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	199	-293	67.3	-1,110	-259
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	34.4	22.3	-47.3	400	-347